NCT02172378View on ClinicalTrials.gov

12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium inhalation capsules

DRUG

Placebo inhalation capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172378 - 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales | Biotech Hunter | Biotech Hunter